In vitro responses of neurofibroma fibroblasts, mast cells and Schwann cells obtained from patients with neurofibromatosis 1 to 308-nm excimer light and/or vitamin D3

J Dermatol. 2013 Sep;40(9):743-5. doi: 10.1111/1346-8138.12242. Epub 2013 Jul 16.

Abstract

Fibroblasts, mast cells and Schwann cells were isolated from neurofibromas of patients with neurofibromatosis 1, and their responses to 308-nm excimer light irradiation and/or vitamin D3 or an analog (tacalcitol; 1,24-dihydroxyvitamin D3 ) were examined in vitro. Excimer light irradiation (300 mJ/cm(2) ) suppressed the growth of all three cell types. Exposure to 10(-7) mol/L of 1α,25(OH)2 D3 (VD3 ) or tacalcitol suppressed the growth of fibroblasts and mast cells, but not Schwann cells. These results suggest that the different neurofibroma cell types show different responses to VD3 . A combination of excimer light irradiation and VD3 is necessary to suppress the growth of neurofibroma cells in vivo.

Keywords: Schwann cells; mast cells; neurofibromatosis 1; ultraviolet light; vitamin D3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Dermatologic Agents / therapeutic use*
  • Dihydroxycholecalciferols / therapeutic use*
  • Drug Screening Assays, Antitumor
  • Fibroblasts / drug effects
  • Fibroblasts / radiation effects
  • Humans
  • Lasers, Excimer / therapeutic use*
  • Low-Level Light Therapy*
  • Mast Cells / drug effects
  • Mast Cells / radiation effects
  • Neurofibromatosis 1 / drug therapy*
  • Neurofibromatosis 1 / radiotherapy
  • Schwann Cells / drug effects
  • Schwann Cells / radiation effects

Substances

  • Dermatologic Agents
  • Dihydroxycholecalciferols
  • 1 alpha,24-dihydroxyvitamin D3